Learn How to Streamline the Regulatory Approval Process and Accelerate Time to Market at the Medical Device Manufacturer’s Association Annual Conference
Across Systems will be attending the 2014 MDMA Annual Conference to meet with interested parties about ways to streamline the regulatory approval process in Washington DC May 14 – 16, 2014.
Glendale, CA, USA, 8th May 2014 – Across Systems, a leading software platform for all corporate language resources and translation processes, announced today that the Company will be attending the 2014 Medical Device Manufacturer’s Association Annual Conference to meet with interested parties about ways to streamline the regulatory approval process. The conference will take place in Washington DC May 14 – 16, 2014.
The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies. This year’s meeting will provide the latest on regulatory, reimbursement, compliance and international trends, as well as share powerful stories of how med tech is improving patient care.
A strategic imperative for the med tech industry is accelerating product time to market which leads to increased competitive advantage, faster time to profit and reduced product development costs. However, due to global situations, translation issues can significantly impact the ability to get a product to market quickly by delaying the time it takes to receive regulatory and patent approvals.
A regulatory approval that is denied because of inaccurate translation can take up to a year before becoming eligible to reapply which delays the product getting to market and opens the door for competition.
Nancy Cardone, Business Development Manager for Across Systems will be in attendance at the MDMA Annual Conference to share valuable advice on how to minimize risk through the use of Across‘ innovative translation management software.
“Based on past conversations with customers and prospects, thinking through the translation process prior to regulatory or patent submissions saves a lot of headaches at the end of the process.“ says Cardone. “Inaccurate or low quality translations can prevent a company from gaining approval and hold up the process for up to one year giving competitors the opportunity to gain market advantage.“
Interested parties may contact Cardone to set up a time for a personal consultation and to learn more about Across System’s innovative translations solutions by emailing her at ncardone[at]across[dot]net.
For more information regarding Across visit www.across.net.
For MDMA general information, schedule, and registration, please visit http://www.medicaldevices.org.
About Across Systems:
Across, based in Karlsbad, Germany, and in Glendale, CA, USA, is the manufacturer of the Across Language Server, a market-leading software platform for all corporate language resources and translation processes. Within a very short time, the use of Across can increase the translation quality and transparency, while reducing the workload and process costs.
The Across Language Server can be used for EN 15038:2006-compliant translation services. As Across Systems GmbH is a certified Microsoft partner, the successful introduction of Microsoft technologies is guaranteed. Thanks to the Software Development Kit (SDK), Across can easily be integrated in IT environments. Integration support is available from the company’s Business Services & Support department and from renowned system integrators and technology partners.
Within the scope of its product development, Across collaborates with international universities and academies. For many years, Across has also been focusing on cooperative partnerships with renowned technology companies and language service providers.
Customers of Across (extract): 1&1 Internet AG, Allianz Versicherungs AG, HypoVereinsbank, Miele, SMA Solar Technology AG, ThyssenKrupp, etc.
Further information about Across Systems GmbH is available at http://www.across.net
